ARHGAP22 and diabetic kidney disease: Although our study had over 80% power (α = 0.05) to detect an OR≥ 1.5 for the risk of DKD, and sample sizes were aligned with ourcalculations, we cannot completely rule out the chance that thers3844492/ARHGAP22 and rs741301/ELMO1polymorphisms may be associated with DKD at lower ORs.